UTMC patients part of national study on COVID drugs

January 7, 2021 | COVID-19, UToledo in the News, UTMC
By Tyrel Linkhorn



Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the hospital’s participation in a nationwide NIH study examining a pair of monoclonal antibodies to treat COVID-19. The study is aimed at quickly identifying therapeutics worthy of larger clinical trials.

Read: UTMC patients part of national study on COVID drugs